Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Acceptability of Deferiprone DR in Iron Overload
NCT03802916Phase 2Completed
- Sponsor
- ApoPharma Inc.
- Start
- Mar 2019
- Primary completion
- Dec 2019
- Modality
- Small Molecules
- Countries
- 4
01
Overview
A Phase 2 trial of deferiprone in iron overload, sponsored by ApoPharma Inc.. Started Mar 2019; status: completed.
02
Drugs
deferiprone
03
Conditions
iron overload
Beyond the preview
Go deeper on NCT03802916.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03802916.